KhabarCheckखबर चेक
← Top Stories

VYLOY (zolbetuximab) in combination with chemotherapy is NOW AVAILABLE and approved for first-line treatment of eligible* adult patients with gastric or gastroesophageal junction adenocarcinoma in India

Partially corroborated51

– VYLOY is the first and only CLDN18.2-targeted treatment approved in the India for adult patients with HER2 negative gastric and gastroesophageal junction (GEJ) adenocarcinoma whose tumors are CLDN18.2 positive – – Central Drugs Standard Control Organization approval was based on the global Phas...

First seen · latest update · India · other

Developing: this story surfaced recently from a single outlet. It appears early by design — expect the reporting-confidence score to move as more outlets report (or don’t).

  • Indian mainstream 0
  • Indian independent 1
  • International 0
  • Official 0
Share

Coverage (1)

See a mistake? Wrong summary · Wrongly grouped · Missing source · Wrong category/region · Dispute outlet rating — each opens a pre-filled report on GitHub.